Safe, accurate, affordable and automated sample collection and diagnosis of TB at point of care

Problem

Sputum samples for diagnosis of TB are currently collected
from patients at healthcare centres in plastic bottles. This
process exposes healthcare workers to the risk of infection
while collecting samples. Diagnosis of TB with these
samples is done through sputum smear microscopy — a
time consuming process with low accuracy which also
requires skilled lab technicians. These result in delayed
diagnosis & initiation of treatment, missed cases of TB and
increased risk of infection to healthcare workers.

Solution

AutoGene enables safe capture of sputum samples from patients in specially designed bottles, which protect the healthcare worker from exposure to pathogens. It provides rapid, accurate and affordable TB diagnosis without the need for skilled technicians at primary health settings. The device includes an RT-PCR diagnosis capability with an automatic gene detection feature (AutoGene T B) which can be used for a broad range of applications including DNA isolation & extraction enabling faster sample processing. The platform is completely automated platform right from sample processing to report generation. Autogene can also be used for the diagnosis of several bacterial and viral diseases including T B, COVID-19, Typhoid, and Sepsis.

IMPACT

Autogene will potentially de-risk healthcare providers by minimizing their exposure to infectious bacteria. The AutoGene test has demonstrated more than 90% diagnostic accuracy in lab settings which will be further validated in real world settings. At one third the cost of comparable tests, Autogene has the potential for widespread use in primary care settings around the world.
“The core idea was to make the best healthcare technologies accessible to everyone and we started from diagnostics. India is highly burdened with infectious diseases like typhoid and tuberculosis which cause high mortality and morbidity every year. A major number of these diseases come from underprivileged locations so there is a need for technology that can reach such locations and also cost-effective.”

Saurabh Singh, Co-founder, Valetude Primus Healthcare